logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Proteases And Their Inhibitors In Cancer Metastasis 1st Edition Jeanmichel Foidart

  • SKU: BELL-2423790
Proteases And Their Inhibitors In Cancer Metastasis 1st Edition Jeanmichel Foidart
$ 31.00 $ 45.00 (-31%)

4.4

102 reviews

Proteases And Their Inhibitors In Cancer Metastasis 1st Edition Jeanmichel Foidart instant download after payment.

Publisher: Springer
File Extension: PDF
File size: 3.4 MB
Pages: 263
Author: Jean-Michel Foidart, Ruth J. Muschel
ISBN: 9781402009235, 1402009232
Language: English
Year: 2002
Edition: 1

Product desciption

Proteases And Their Inhibitors In Cancer Metastasis 1st Edition Jeanmichel Foidart by Jean-michel Foidart, Ruth J. Muschel 9781402009235, 1402009232 instant download after payment.

In recent years, serine proteases and matrix metalloproteinases (MMPs) have gained considerable attention in tumor biology. For most of these proteases, their expression is a reliable indication of ongoing tissue remodeling. This book provides a comprehensive evaluation of the mechanisms of action of proteases and their inhibitors in tumor biology. The first part provides the reader with a selective overview of the molecular biology of serine proteases, MMPs and their physiological inhibitors. The most important proteases and their physiological as well as synthetic inhibitors are evaluated in the most relevant models of experimental and human cancer. The clinical aspects are also taken into account. This volume offers an update on this challenging aspect of cancer treatment, its interest bias, and possible clinical implication.

Related Products